A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1999
12/14/1999	US6001849 Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission
12/14/1999	US6001834 [(4-heteroaryl-1-piperazinyl)alkoxy]-3,4-dihydro-1(2h)-naphthalenones and related compounds and their therapeutic utility
12/14/1999	US6001832 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
12/14/1999	US6001830 Heterocyclic compounds
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999	US6001581 Cation-based bioassay using human metabotropic glutamate receptors
12/14/1999	US6001390 Formulations for transdermal delivery of pergolide
12/14/1999	US6000772 Tubulin promoter regulates gene expression in neurons
12/14/1999	CA2155024C Genetic modification of neural stem cells
12/14/1999	CA2135487C Heteroaromatic quinuclidinenes, their use and preparation
12/12/1999	CA2274202A1 Diaza-spiro[3,5]nonane derivatives
12/09/1999	WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS)
12/09/1999	WO1999062902A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999	WO1999062899A1 Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition
12/09/1999	WO1999062888A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999	WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999	WO1999062879A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
12/09/1999	WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999	WO1999062548A1 Methods and compositions for diagnosing tauopathies
12/09/1999	WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999	WO1999062531A1 Monoamine oxidase (mao) inhibitors and uses thereof
12/09/1999	WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999	WO1999062522A1 Combination therapy for treatment of bipolar disorders
12/09/1999	WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999	WO1999062515A1 Heterocyclic cis cyclopropane derivatives as melatonergic agents
12/09/1999	WO1999062511A1 Neurotrophic difluoroamide agents
12/09/1999	WO1999062506A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/09/1999	WO1999062505A2 Method for treating neurodegenerative disorders
12/09/1999	WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999	WO1999062496A1 Methods and devices for providing prolonged drug therapy
12/09/1999	WO1999051591A3 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
12/09/1999	WO1999046367A3 Methods of diagnosis and triage using cell activation measures
12/09/1999	WO1999043285A3 Sulphonamide derivatives
12/09/1999	WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999	CA2334299A1 Heterocyclic cis cyclopropane derivatives as melatonergic agents
12/09/1999	CA2334186A1 Monoamine oxidase (mao) inhibitors and uses thereof
12/09/1999	CA2333997A1 Neurotrophic difluoroamide agents
12/09/1999	CA2333964A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999	CA2333960A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
12/09/1999	CA2333756A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999	CA2333688A1 Methods and devices for providing prolonged drug therapy
12/09/1999	CA2332408A1 Combination therapy for treatment of bipolar disorders
12/09/1999	CA2330179A1 Human homologue of unc-53 protein of c. elegans
12/08/1999	EP0962457A1 Piperidones as tachykinin antagonists
12/08/1999	EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999	EP0961617A1 Leukotriene antagonists for cerebral focal stroke
12/08/1999	EP0775158B1 Cyclopeptolides
12/08/1999	EP0771196B1 Excitatory amino acid receptor antagonists
12/08/1999	EP0712387B1 2-aminoindans as selective dopamine d3 ligands
12/08/1999	EP0674631B1 Substituted pyrazoles as crf antagonists
12/08/1999	EP0660718B1 Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
12/08/1999	CN1237978A N (aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds
12/08/1999	CN1237962A Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
12/08/1999	CN1237960A N (aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds
12/08/1999	CN1237909A Cancer immunotherapy using tumor cells combined with mixed lymphocytes
12/08/1999	CN1047169C Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives, and its use and medicinal preparation
12/08/1999	CN1047168C (S)-a-phenyl-2-pyridineethanamine(s)-malate, and its preparing method and use
12/07/1999	US5998666 Phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same
12/07/1999	US5998665 Therapy for nervous system disorders
12/07/1999	US5998630 A 1-(3-(1-pyrrolidinyl)propy)-3-ethylcarbodiimide
12/07/1999	US5998622 Analgesics; antiinflammatory agents; side effect reduction
12/07/1999	US5998615 Alzheimer's disease; nervous system disorders
12/07/1999	US5998613 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
12/07/1999	US5998583 BH3 interacting domain death agonist
12/07/1999	US5998579 Epimorphin antagonist and process for producing it
12/07/1999	US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999	US5998480 Pharmaceutical preparation containing nimesulide for topical use
12/07/1999	US5998474 Reduction of oxygen free radicals; nervous system disorders,cardiovascular disorders
12/07/1999	US5998469 Nervous system diosrders; autoimmune diseases; antiinflammatory agents
12/07/1999	US5998460 Phenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-N1-benzylnoreseroline: selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof
12/07/1999	US5998429 Azabicyclic esters of carbamic acids useful in therapy
12/07/1999	US5998417 N-[(4-heteroaryl-1-piperazinyl) alkyl]phthalimides and related compounds and their therapeutic utility
12/07/1999	US5998405 Psychological disorders
12/07/1999	US5998404 Nervous system disorders
12/07/1999	US5998388 Adenosine derivatives
12/07/1999	US5997880 Method for alleviating varicella related post-herpetic neuralgia
12/07/1999	US5997863 Attenuation of wound healing processes
12/07/1999	CA2214575C Paroxetine tablets and process to prepare them
12/07/1999	CA2211522C Novel compounds
12/07/1999	CA2198231C Dihydropyridine derivatives as bradykinin antagonists
12/07/1999	CA2161886C Heteroatom substituted alkylbenzylaminoquinuclidines
12/07/1999	CA2012686C Treatment and compounds
12/02/1999	WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999	WO1999061617A1 Interleukins-21 and 22
12/02/1999	WO1999061614A2 Human socs proteins
12/02/1999	WO1999061609A1 Calmodulin related protein
12/02/1999	WO1999061471A2 Human transmembrane proteins
12/02/1999	WO1999061459A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999	WO1999061440A1 Novel substituted imidazole compounds
12/02/1999	WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999	WO1999061424A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
12/02/1999	WO1999061423A1 New heterocyclically substituted amides, their production and their use
12/02/1999	WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999	WO1999061419A1 Prostaglandin derivative
12/02/1999	WO1999061066A2 Convection-enhanced delivery of aav vectors
12/02/1999	WO1999061054A1 Nicotine immunogen
12/02/1999	WO1999061043A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1

1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 1833